Rezolute, Inc. (RZLT): Operating Income
-$82.97M
Year ended 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$82.97M | n/m | 2026-09-24, From 2025-07-01 |
| 2025-06-30 | -$79.89M | n/m | 2026-09-24, From 2024-07-01 |
| 2024-06-30 | -$70.42M | n/m | 2025-09-17, From 2023-07-01 |
| 2023-06-30 | -$55.99M | n/m | 2024-09-19, From 2022-07-01 |
| 2022-06-30 | -$41.84M | n/m | 2023-09-14, From 2021-07-01 |
| 2021-06-30 | -$22.89M | n/m | 2022-09-15, From 2020-07-01 |
| 2020-06-30 | -$20.52M | n/m | 2021-09-15, From 2019-07-01 |
| 2019-06-30 | -$25.94M | n/m | 2020-10-13, From 2018-07-01 |
| 2018-06-30 | -$28.73M | n/m | 2019-09-10, From 2017-07-01 |
| 2017-06-30 | -$20.32M | n/m | 2018-10-15, From 2016-07-01 |
| 2016-06-30 | -$14.95M | n/m | 2017-09-22, From 2015-07-01 |
| 2015-06-30 | -$10.70M | n/m | 2016-09-28, From 2014-07-01 |
| 2014-06-30 | -$5.18M | n/m | 2015-09-28, From 2013-07-01 |
| 2013-06-30 | -$6.11M | n/a | 2014-09-30, From 2012-07-01 |
| No annual figure between 2011-12-31 and 2013-06-30. | |||
| 2011-12-31 | -$393.0K | n/a | 2013-09-11, From 2011-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Rezolute, Inc. (RZLT) | 2026-06-30 | -$82.97M | n/m |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | -$121.86M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | -$62.14M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$29.16M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$72.92M | n/m |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | -$56.89M | n/m |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | -$86.21M | n/m |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | -$62.73M | n/m |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$90.71M | n/m |
Compare RZLT, KRRO, MIST, RFL side by side · Screen every company in Pharmaceutical Preparations ↗